Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

GNPX Genprex Inc

-0.25 (-10.33%)
Jun 15 2024 - Closed
Delayed by 15 minutes


Draw Mode:

Volume 81,619
Bid Price 2.22
Ask Price 5.54
News -
Day High 2.47


52 Week Range


Day Low 2.12
Company Name Stock Ticker Symbol Market Type
Genprex Inc GNPX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.25 -10.33% 2.17 00:00:05
Open Price Low Price High Price Close Price Prev Close
2.47 2.12 2.47 2.17 2.42
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
516 81,619 $ 2.25 $ 183,478 - 2.09 - 42.00
Last Trade Time Type Quantity Stock Price Currency
19:49:47 1 $ 2.22 USD

Genprex Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
3.21M 1.49M - 0 -30.86M -20.77 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Genprex News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No GNPX Message Board. Create One! See More Posts on GNPX Message Board See More Message Board Posts

Historical GNPX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week2.5952.632.122.4846,725-0.425-16.38%
1 Month2.424.08992.103.02258,005-0.25-10.33%
3 Months3.004.08992.092.94110,349-0.83-27.67%
6 Months8.8614.402.097.66278,392-6.69-75.51%
1 Year34.4042.002.0918.58396,946-32.23-93.69%
3 Years145.20155.602.0995.74843,107-143.03-98.51%
5 Years56.00308.802.09117.311,276,677-53.83-96.13%

Genprex Description

Genprex, Inc. is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Genprex's technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex works with world-class institutions and collaborators to develop drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches. Genprex's oncology program utilizes its systemic, non-viral Oncoprex® Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The resultant product is administered intravenously, where it is taken up by tumor cells that then express tumor suppressor proteins that were deficient in the tumor.

Your Recent History

Delayed Upgrade Clock